103904-69-4

Basic information

• Product Name: 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>cyclohexanone
• Synonyms: 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>cyclohexanone
• CAS NO: 103904-69-4
• Molecular Weight: 281.739
• Mol File: 103904-69-4.mol
• Article Data: 4

Chemical Properties

• CAS DataBase Reference: 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>cyclohexanone(CAS DataBase Reference)
• NIST Chemistry Reference: 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>cyclohexanone(103904-69-4)
• EPA Substance Registry System: 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>cyclohexanone(103904-69-4)

Safety Data

• Hazardous Substances Data: 103904-69-4(Hazardous Substances Data)

Upstream product

• 79499-57-3 (±)-1-((2-chlorophenyl)(imino)methyl)cyclopentan-1-ol 
• 17465-36-0 2'-chloro-2,3,4,5-tetrahydro-1,1'-biphenyl 
• 91767-28-1 1-(2-chlorophenyl)-cyclohexane-1-ol 
• 108-94-1 cyclohexanone 
• 694-80-4 2-bromo-1-chlorobenzene 
• 79-22-1 methyl chloroformate 
• 35211-10-0 norketamine 

Downstream Products

• 120199-64-6 2-Hydroxy-Norketamine 
• 103904-72-9 Toluene-4-sulfonic acid (1S,3S)-3-(2-chloro-phenyl)-3-methoxycarbonylamino-2-oxo-cyclohexyl ester 
• 103904-71-8 [(1S,3S)-1-(2-Chloro-phenyl)-2-oxo-3-trimethylsilanyloxy-cyclohexyl]-carbamic acid methyl ester 
• 103904-70-7 2-(o-chlorophenyl)-2-<(methoxycarbonyl)amino>-6-hydroxycyclohexanone 
• 104010-58-4 (Z)-6-hydroxynorketamine 
• 103933-03-5 methyl (2'-chloro-6-((trimethylsilyl)oxy)-1,2,3,4-tetrahydro-[1,1'-biphenyl]-1-yl)carbamate 

Relevant articles and documents

HYDROXYNORKETAMINE DERIVATIVES FOR THE TREATMENT OF CNS DISORDERS

Chemical entities of Formula (I): Including enantiomers thereof, wherein R1 has any of the values described herein, and compositions comprising such chemical entities; their preparation; and their use in various methods, including the treatment of depression, pain, cognitive disorders, neurodegenerative disorders, and other neurological and peripheral disorders.

SOLID ORAL DOSAGE FORMS OF 2R,6R-HYDROXYNORKETAMINE OR DERIVATIVES THEREOF

This invention relates to solid oral dosage forms of 2R,6R-hydroxynorketamine or prodrugs thereof having Formula Ib, including any pharmaceutically acceptable salt of the foregoing, for use in a therapeutic method for the treatment of a depressive disorder in a patient.